Literature DB >> 2323810

Compartmental heterogeneity of soluble phospholipases A.

P Vadas1, W Pruzanski, E Stefanski, B Sternby.   

Abstract

Multiple forms of soluble phospholipase A2 (PLA2) are known to coexist in venoms of individual reptilian species. While similar observations in several mammalian species suggest that this is a common phenomenon, the functional implications are not yet understood. In attempting to devise therapeutic strategies for treatment of inflammatory disorders by inhibition of PLA2, it is imperative to define the various PLA2 species in the relevant compartments. Herein, we report the presence of three PLA2 isotypes in rheumatoid arthritis serum, one pancreatic and two nonpancreatic phospholipases A2. The pancreatic and one of the nonpancreatic forms were optimally active in 7 mM calcium at pH 7.5. The other nonpancreatic form was calcium-independent and optimally active at pH 7.0. Only the calcium-dependent nonpancreatic form was observed in rheumatoid synovial fluid. Of the three serum isotypes, only the calcium-dependent nonpancreatic form correlated with markers of disease activity, such as the joint count and Landsbury index. Therefore, not all soluble or circulating phospholipases A2 are relevant to inflammatory processes. Selective inhibition of the proinflammatory form of PLA2 may prove to have some therapeutic benefit while minimizing the possible adverse effects of this form of intervention.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323810     DOI: 10.1007/bf00917456

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  41 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations.

Authors:  J LANSBURY
Journal:  Arthritis Rheum       Date:  1958-12

3.  Phospholipase activity associated with serum albumin.

Authors:  P Elsbach; P Pettis
Journal:  Biochim Biophys Acta       Date:  1973-01-19

Review 4.  The role of phospholipase A in acute pancreatitis.

Authors:  T J Nevalainen
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

5.  Phospholipase A2 activity of lysosomal origin secreted by polymorphonuclear leucocytes during phagocytosis or on treatment with calcium.

Authors:  J R Traynor; K S Authi
Journal:  Biochim Biophys Acta       Date:  1981-09-24

6.  Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?

Authors:  P Vadas; W Pruzanski; E Stefanski
Journal:  Agents Actions       Date:  1988-07

7.  Structure and properties of a human non-pancreatic phospholipase A2.

Authors:  R M Kramer; C Hession; B Johansen; G Hayes; P McGray; E P Chow; R Tizard; R B Pepinsky
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

8.  Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid.

Authors:  B S Vishwanath; A A Fawzy; R C Franson
Journal:  Inflammation       Date:  1988-12       Impact factor: 4.092

9.  Influence of plasma proteins on activity of proinflammatory enzyme phospholipase A2.

Authors:  P Vadas; E Stefanski; W Pruzanski
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

10.  Methyltransferase and phospholipase A2 activity in the cell membrane of neutrophils and lymphocytes from patients with Behçet's disease, systemic lupus erythematosus, and rheumatoid arthritis.

Authors:  Y Niwa; Y Miyachi; T Sakane; T Kanoh; S Taniguchi
Journal:  Clin Chim Acta       Date:  1988-05-13       Impact factor: 3.786

View more
  4 in total

1.  Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids.

Authors:  W Pruzanski; K Scott; G Smith; I Rajkovic; E Stefanski; P Vadas
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

2.  Selective inhibition of group II phospholipase A2 by quercetin.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

3.  Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1997-06       Impact factor: 4.092

4.  Induction of circulating phospholipase A(2) by intravenous administration of recombinant human tumour necrosis factor.

Authors:  W Pruzanski; M L Sherman; D W Kufe; P Vadas
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.